GUERZONI, S.; LO CASTRO, F.; BARALDI, C.; BROVIA, D.; TASCEDDA, F.; RIVI, V.; PANI, L. Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache. Confinia Cephalalgica, [S. l.], v. 34, n. 1, 2024. DOI: 10.4081/cc.2024.15760. Disponível em: https://www.confiniacephalalgica.com/site/article/view/15760. Acesso em: 5 oct. 2024.